US Stocks
/
Oruka Therapeutics, Inc. Share Price

Oruka Therapeutics, Inc. Share Price

NASDAQ: ORKA | Mid Cap
$94.79
-$2.97 (-3.04%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Oruka Therapeutics, Inc. Stock Performance

Open
$97.62
Prev. Close
$97.76
Circuit Range
N/A
Day Range
$94.78 - $97.62
Year Range
$14.99 - $115.52
Volume
53,638
Average Traded
$95.67

Oruka Therapeutics, Inc. Share Price Today

As of 19 September 2026, Oruka Therapeutics, Inc.'s share price is $94.79. The stock opened at $97.62, compared to its previous close of $97.76. During today's trading session, Oruka Therapeutics, Inc.'s share price traded between $94.78 and $97.62, with an average price of $96.20. Over the past 52 weeks, the stock has recorded a high of $115.52 and a low of $14.99. In terms of performance, Oruka Therapeutics, Inc.'s share price has risen by 93.13% over the last six months and is up 390.12% on a year-on-year basis.

Oruka Therapeutics, Inc. Share Price Chart

$94.78$97.62
L
Show Current Price
H

Oruka Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.32B
PE Ratio (TTM)
-51.24
Dividend Yield
N/A
EPS (TTM)
$-1.85
Revenue (TTM)
N/A
Return On Equity (TTM)
-22.34%
Profit Margin
N/A
Debt to Equity
0.03
Quarterly Earnings Growth YoY
N/A

Oruka Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2025
RevenueN/AN/AN/A
Net Profit-$2.01M-$2.68M-$30.28M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-33.30%-1030.58%

Oruka Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202120222025
RevenueN/AN/AN/A
Net Profit-$19.32M-$9.93M-$105.43M
Net Profit MarginN/AN/AN/A
Income ChangeN/A48.63%-962.19%

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Oruka Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$91.37
$94.95
-1.51%
Aug 2026
$94.78
$96.41
-0.15%
Jul 2026
$94.76
$96.55
+1.44%
Jun 2026
$57.42
$95.17
+62.75%
May 2026
$68.50
$58.48
-14.79%
Apr 2026
$49.50
$68.63
+39.83%
Mar 2026
$33.70
$49.08
+42.63%
Feb 2026
$34.65
$34.41
+0.56%
Jan 2026
$30.35
$34.22
+12.77%
Dec 2025
$28.90
$30.34
+0.58%
Nov 2025
$27.39
$30.17
+7.18%
Oct 2025
$19.41
$28.15
+45.55%

ORKA Share Price FAQs

What is Oruka Therapeutics, Inc. share price today?

chevron-up
Oruka Therapeutics, Inc. share price today is $94.79 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Oruka Therapeutics, Inc. stock?

chevron-up
The 52 week high of Oruka Therapeutics, Inc. stock is $115.52, while the 52 week low is $14.99 as of 19 Sep '26.

What is ORKA's market capitalisation today?

chevron-up
ORKA market capitalisation is $4.32B as of September 19, 2026, at 10:40 pm IST.

What is ORKA's net income for the last quarter?

chevron-up
ORKA's net income for the last quarter is -0.03B USD.

What is the 5 year returns of ORKA?

chevron-up
The 5 year returns of ORKA is 166.86% as on 19 Sep '26.

What is the high & low stock price of ORKA today?

chevron-up
ORKA stock price hit a high of $97.62 and low of $94.78 as of 19 Sep '26.

Can I buy ORKA shares in India?

chevron-up
Yes. You can buy ORKA in India by opening an international trading account.